Manufacturer savings cards bring the cost to $25 per fill for commercially insured patients
Pharmacotherapy Obesity pharmacotherapy has recently experienced a revolution with the advent of glucagon-like-peptide (GLP)-1 agonists (for example, semaglutide), and subsequently multi-incretin receptor agonists including dual agonists (for example, gastric inhibitory polypeptide (GIP) analogue and a GLP-1 receptor agonist, Tirzepatide) and triple agonists (for example, GLP-1, GIP, and glucagon receptor (GCGR), Retatrutide)
Cell Stem Cell (2009) 4:31323
This delayed gastric emptying is what creates the appetite-suppressing effectbut it also triggers sensations of pressure, bloating, and mild cramping as your stomach adjusts to processing food more slowly
The AM packet focuses on bone, immune, and muscle preservation support to carry you through the day